Search

everythinglearnresearchcommunity

for

Search:↓

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Females with 5 alpha-reductase-2 deficiency have less body hair, no acne, normal fertility, and delayed menarche.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

The same gene mutation can cause different symptoms in family members.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Fibroblasts help understand androgen resistance at the cellular level.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Scrotal rejuvenation treats aging-related changes in men's scrotum using methods like medication, hair transplantation, and surgery.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.